Genetic Testing: Decoding Your PRKN Results

Navigating a diagnosis of PRKN-related Parkinson’s disease often begins with a complex piece of paper: your genetic test report. Unlike the more common forms of Parkinson’s, which are often sporadic, this form is strictly tied to how your genes were inherited from your parents. Understanding the “architecture” of your PRKN variants is essential, as certain standard tests can sometimes miss half of the picture.

The Logic of Biallelic Inheritance

Your body carries two copies of the PRKN gene—one from your mother and one from your father. PRKN-related Parkinson’s follows an autosomal recessive inheritance pattern ^[1]. This means that for the disease to develop, both copies of the gene must have a pathogenic (disease-causing) variant ^[2]. This state is called being biallelic.

• Homozygous: You have the exact same pathogenic variant on both copies of the gene ^[3].
• Compound Heterozygous: You have two different pathogenic variants—one on the mother’s copy and a different one on the father’s copy ^[1].
• Carriers (Heterozygous): If you have only one mutated copy, you are a “carrier.” Carriers generally do not have this form of Parkinson’s, and a single variant (or a Variant of Uncertain Significance - VUS) does not establish a diagnosis of PRKN-PD ^[1].

Why Comprehensive Testing Matters

If you have symptoms of early-onset Parkinson’s but your genetic test only found one PRKN mutation, the test may have been incomplete. A significant portion of PRKN mutations are structural variants—also known as copy-number variants (CNVs) ^[4][5].

These are not simple “typos” in the DNA code; they are entire sections of the gene that have been deleted or duplicated ^[6]. Some older or basic sequencing tests (which “read” the DNA letter by letter) can miss these large-scale changes ^[7]. To find them, your testing panel must include specific analysis like deletion/duplication analysis or MLPA (Multiplex Ligation-dependent Probe Amplification) ^[7][8]. In cases where a second pathogenic variant is still missing, advanced specialist-directed tools like long-read sequencing or whole-genome sequencing can sometimes find “hidden” mutations that other tests miss ^[9][10].

Implications for Your Family and Reproductive Risk

Because PRKN-related Parkinson’s is recessive, the way it travels through a family is predictable but requires careful math and counseling.

• Siblings: If both of your parents are unaffected carriers, each of your full siblings has a 25% chance of also having the disease, a 50% chance of being a carrier, and a 25% chance of carrying no variants ^[1]. Because symptoms can be subtle early on, siblings may choose to undergo targeted testing for your specific variants, but this should ideally involve genetic counseling first regarding the psychological and insurance implications.
• Your Children: If you are affected (biallelic), you will pass one pathogenic variant to all of your biological children, making them obligate carriers ^[11]. The risk of your child actually developing the disease depends on your partner:
  • If your partner has a negative carrier screen (no variants), the risk of your child having the disease is very low, though a small residual risk remains.
  • If your partner is a carrier (has one variant), each pregnancy has a 50% chance of the child having the disease and a 50% chance of being a carrier.
  • If your partner is also affected (has two variants), all children will have the disease.

Planning for the Future

For those considering starting or growing a family, consulting a genetic counselor is highly recommended to clarify these risks:

• Partner Testing: Your partner can undergo “carrier screening” to clarify the genetic landscape ^[11].
• Preimplantation Genetic Testing (PGT-M): For couples where the risk is high, PGT-M is a value-sensitive option used during IVF (in vitro fertilization) ^[12]. Embryos are tested in a lab, and only those without the biallelic disease genotype are selected for transfer ^[13][14].
• Prenatal Diagnosis: If a pregnancy has already begun, procedures like amniocentesis or chorionic villus sampling (CVS) can determine the fetal genotype ^[15].

A genetic counselor can help you interpret your specific report, confirm variant classification, and discuss which of these options align with your personal values and goals.